Skip to main content

Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy

Buy Article:

$43.00 plus tax (Refund Policy)


Hyperammonaemic encephalopathy has been infrequently reported after both standard and high-dose chemotherapy for solid and haematological malignancies. It is important to consider this diagnosis for patients with unexplained behaviour changes or encephalopathy and this case report emphasizes this condition and the importance of early diagnosis and is the first reported in association with rituximab-containing chemotherapy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: chemotherapy; hyperammonaemic encephalopathy; rituximab

Document Type: Research Article

Affiliations: 1: Department of Oncology, The Queen Elizabeth Hospital 2: Intensive Care Unit, Wakefield Hospital 3: Department of Biochemistry, Women and Children Hospital, Adelaide, Australia

Publication date: 01 October 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more